Skip to main content

Table 2 Severity of nausea

From: Adding aprepitant to palonosetron does not decrease carboplatin-induced nausea and vomiting in patients with gynecologic cancer

  Control group (n = 52) Aprepitant group (n = 54) P-value
Grade 0 Grade 1 Grade 2 Grade 0 Grade 1 Grade 2
Acute phase 51 1 0 54 0 0 0.32
Delayed phase 39 9 4 40 8 6 0.85